Annovis Bio, Inc. (ANVS)
0.8449
+0.18
(+26.31%)
USD |
NYSE |
Nov 06, 16:00
0.9517
+0.11
(+12.64%)
After-Hours: 20:00
Annovis Bio Price : 0.8449 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 0.70 | 0.8527 | 0.6301 | 0.8449 | 11.74M |
| Nov 05, 2026 | 0.88 | 0.906 | 0.6161 | 0.6689 | 30.87M |
| Nov 04, 2026 | 1.12 | 1.25 | 1.10 | 1.21 | 1.433M |
| Nov 03, 2026 | 1.07 | 1.15 | 1.06 | 1.09 | 681457.0 |
| Nov 02, 2026 | 1.17 | 1.395 | 1.05 | 1.08 | 3.012M |
| Oct 30, 2026 | 1.02 | 1.17 | 1.01 | 1.13 | 1.499M |
| Oct 29, 2026 | 1.01 | 1.050 | 1.00 | 1.02 | 1.483M |
| Oct 28, 2026 | 0.98 | 1.03 | 0.98 | 1.02 | 913528.0 |
| Oct 27, 2026 | 0.95 | 1.03 | 0.95 | 1.00 | 913324.0 |
| Oct 26, 2026 | 1.00 | 1.00 | 0.9295 | 0.957 | 593160.0 |
| Oct 23, 2026 | 0.99 | 1.01 | 0.961 | 0.9993 | 317231.0 |
| Oct 22, 2026 | 0.99 | 1.05 | 0.98 | 0.9917 | 448443.0 |
| Oct 21, 2026 | 1.00 | 1.04 | 0.9878 | 0.9932 | 546329.0 |
| Oct 20, 2026 | 0.96 | 1.04 | 0.96 | 0.9783 | 703977.0 |
| Oct 19, 2026 | 0.995 | 1.04 | 0.95 | 0.96 | 641350.0 |
| Oct 16, 2026 | 1.06 | 1.08 | 0.987 | 0.9934 | 641423.0 |
| Oct 15, 2026 | 1.04 | 1.075 | 1.01 | 1.05 | 572216.0 |
| Oct 14, 2026 | 1.05 | 1.08 | 1.01 | 1.02 | 850261.0 |
| Oct 13, 2026 | 1.15 | 1.15 | 1.05 | 1.06 | 851014.0 |
| Oct 12, 2026 | 1.21 | 1.21 | 1.14 | 1.15 | 460230.0 |
| Oct 09, 2026 | 1.17 | 1.24 | 1.14 | 1.21 | 521897.0 |
| Oct 08, 2026 | 1.21 | 1.21 | 1.14 | 1.17 | 815380.0 |
| Oct 07, 2026 | 1.17 | 1.23 | 1.16 | 1.21 | 430012.0 |
| Oct 06, 2026 | 1.20 | 1.24 | 1.17 | 1.18 | 538719.0 |
| Oct 05, 2026 | 1.16 | 1.20 | 1.135 | 1.20 | 657640.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Akebia Therapeutics, Inc. | 0.4013 |
| ACADIA Pharmaceuticals, Inc. | 21.23 |
| Alnylam Pharmaceuticals, Inc. | 155.94 |
| Anika Therapeutics, Inc. | 14.55 |
| Savara, Inc. | 4.83 |
Price Related Metrics
| Earnings Yield | -212.2% |
| Market Cap | 36.00M |